Mary Gullatte Discusses Cancer Genetic Counseling

MARY GULLATTE, PHD, RN, APRN, BC, AOCN, FAAN
Friday, May 25, 2012
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Mary Gullatte, PhD, RN, APRN, BC, AOCN®, FAAN, associate chief nursing officer, Emory University Hospital Midtown, president, Oncology Nursing Society, discusses some of the concerns surrounding the growing field of cancer genetic counseling.

Gullatte explains that as the field grows many perpetrators are beginning to emerge. It is important that genetic counselors are held to the same standards as other medical professionals who require training and certification. This education is important because there is a special body of knowledge that genetic counselors need to know in order to accurately advise patients on the best course of action.

As cancer therapy becomes more personalized and geared towards an individual's genetics, it is increasingly important for a patient to receive counseling. This advice may include the next steps following the detection of a cancer gene, which includes preventing cancer from manifesting or possible prophylactic surgeries or medicines.



Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.